INTERNATIONAL PATENT: VISIRNA THERAPEUTICS (SUZHOU) CO., LTD., 维亚臻生物技术（苏州）有限公司 FILES APPLICATION FOR "RNA INHIBITOR FOR INHIBITING EXPRESSION OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR"

GENEVA, July 28 -- VISIRNA THERAPEUTICS (SUZHOU) CO., LTD. (4 Flour, Building B5, No. 99, Jingu Road, Phase 3, Suzhou Industrial ParkSuzhou, Jiangsu 215028), 维亚臻生物技术（苏州）有限公司 (中国江苏省苏州市苏州工业园区3期金谷路99号B5栋4楼) filed a patent application (PCT/CN2025/073153) for "RNA INHIBITOR FOR INHIBITING EXPRESSION OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR" on Jan 17, 2025. With publication no. WO/2025/153084, the details related to the patent application was published on Jul 24, 2025.

Notably, the patent applicat...